En español

Prescription Drug Abuse


  1. Baillargeon, L.; Landreville, P.; Verreault, R.; Beauchemin, J.-P.; Grégoire, J.-P.; and Morin, C.M. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: A randomized trial. CMAJ 169:1015-1020, 2003.
  2. Boyer, E.W. Dextromethorphan abuse. Pediatr Emerg Care 20(12):858-863, 2004.
  3. Cai, R.; Crane, E.; Poneleit, K.; and Paulozzi, L. Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004-2008. J Pain Palliat Care Pharmacother 24(3):293-297, 2010.
  4. Centers for Disease Control and Prevention (CDC). Unintentional Drug Poisoning in the United States. CDC Data Brief, July 2010.
  5. Cheatle, M.D., and O'Brien, C.P. Opioid therapy in patients with chronic noncancer pain: Diagnostic and clinical challenges. Adv Psychosom Med 30:61-91, 2011.
  6. Cotto, J.H.; Davis, E.; Dowling, G.J.; Elcano, J.C.; Staton, A.B.; Weiss, S.R.B. Gender effects on drug use, abuse, and dependence: An analysis of results from the National Survey on Drug Use and Health. Gend Med 7(5):402-413, 2010.
  7. Dowling, G.J., Weiss, S.R., and Condon, T.P. Drugs of abuse and the aging brain. Neuropsychopharmacology 33(2):209-218, 2008.
  8. Fishbain, D.A.; Cole, B.; Lewis, J.; Rosomoff, H.L.; Rosomoff, R.S. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 9(4):444-459, 2008.
  9. Institute of Medicine (IOM). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: The National Academies Press, 2011. http://www.iom.edu/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research.aspx.
  10. Johnston, L.D.; O'Malley, P.M.; and Bachman, J.G. Monitoring the Future: National Survey Results on Drug Use, Overview of Key Findings 2010. Bethesda, MD: NIDA, NIH, DHHS, 2010. Available at: www.monitoringthefuture.org.
  11. Li, W.; Li, Q.; Zhu, J.; Qin, Y.; Zheng, Y.; Chang, H.; Zhang, D.; Wang, H.; Wang, L.; Wang, Y.; Wang, W. White matter impairment in chronic heroin dependence: a quantitative DTI study. Brain Res 1531:58-64, 2013.
  12. Licata, S.C., and Rowlett, J.K. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav 90(1):74-89, 2008.
  13. Liu, J.; Qin, W.; Yuan, K.; Li, J.; Wang, W.; Li, Q.; Wang, Y.; Sun, J.; von Deneen, K.M.; Liu, Y.; Tian, J. Interaction between dysfunctional connectivity at rest and heroin cues-induced brain responses in male abstinent heroindependent individuals. PLoS One 6(10):e23098, 2011.
  14. Lord, S.; Brevard, J.; and Budman, S. Connecting to Young Adults: An Online Social Network Survey of Beliefs and Attitudes Associated With Prescription Opioid Misuse Among College Students. Substance Use Misuse 46:66-76, 2011.
  15. Maher, B. Poll results: Look who?s doping. Nature 452:674-675, 2008.
  16. McCabe, S.E.; Boyd, C.J.; Cranford, J.A.; and Teter, C.J. Motives for nonmedical use of prescription opioids among high school seniors in the United States, self-treatment and beyond. Arch Pediatr Adolesc Med 163(8):106, 2009.
  17. McCabe, S.E.; Boyd, C.J.; and Teter, C.J. Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend 102:63-70, 2009.
  18. McCabe, S.E.; Teter, C.J.; and Boyd, C.J. Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health 54:269-278, 2006.
  19. National Library of Medicine. Cerebral hypoxia. Available at: https://medlineplus.gov/ency/article/001435.htm. Updated: August 29, 2012. Last accessed: October 30, 2014.
  20. Pleis, J.R.; Lucas, J.W.; and Ward, B.W. Summary health statistics for U.S. adults: National Health Interview Survey, 2008. National Center for Health Statistics. Vital Health Stat 10 (242), 2009.
  21. Qiu, Y.; Jiang, G.; Su, H.; Lv, X.; Zhang, X.; Tian, J.; Zhou, F. Progressive white matter microstructure damage in male chronic heroin dependent individuals: a DTI and TBSS study. PLoS One 8(5):e63212, 2013.
  22. Simoni-Wastila, L.; Ritter, G.; and Strickler, G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse 39(1):1-23, 2004.
  23. Simoni-Wastila, L. The use of abusable prescription drugs: The role of gender. J Womens Health Gend Based Med 9(3):289-297, 2000.
  24. Substance Abuse and Mental Health Services Administration, Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011.
  25. SAMHSA. Misuse of prescription drugs: Data from the 2002, 2003, and 2004 National Surveys on Drug Use and Health. HHS Pub. No. (SMA)06-4192. Rockville, MD: Office of Applied Studies, 2006.
  26. SAMHSA. Detailed Tables: National Estimates, Drug-Related Emergency Department Visits for 2004-2009. Rockville, MD: Office of Applied Studies, 2010. http://www.samhsa.gov/data/DAWN.aspx.
  27. Svetlov, S.I.; Kobeissy, F.H.; and Gold, M.S. Performance enhancing, non-prescription use of Ritalin: A comparison with amphetamines and cocaine. J Addict Dis 26(4):1-6, 2007.

This page was last updated November 2014

Get this Publication

NIDA Notes: The Latest in Drug Abuse Research

​Research Reports

This series of reports simplifies the science of research findings for the educated lay public, legislators, educational groups, and practitioners. The series reports on research findings of national interest.